This study summarizes major work which investigated the roles of glucagon like peptide-1 (GLP-1) and its receptor (GLP-1R); the use of GLP-1-R agonists and dipeptidyl peptidase 4 inhibitor in the management of type 2 diabetes mellitus. It focuses on the recent therapeutic development which has occurred in this field, and also discusses the potential treatments which can be discovered and implemented in the near future to design an effective therapy for type 2 diabetes mellitus.
|Number of pages||5|
|Journal||Diabetes and Metabolic Syndrome: Clinical Research and Reviews|
|Early online date||15 Sep 2016|
|Publication status||Published - 2017|